Advanced Search


Study ID Status Title Patient Level Data
114429 Completed Phase IV Observational Study in Chronic Lymphocytic Leukemia Patients Receiving Ofatumumab in the European Union
114430 Completed Postmarketing hepatic monitoring for Pazopanib using observational databases
114433 Completed An Observer- and Subject-Blinded, Randomized, Placebo-Controlled, Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects
114444 Completed Study to assess the replication of Porcine circovirus type 1 (PCV-1) GSK Biologicals’ oral live attenuated human rotavirus vaccine (444563) recipients aged 6 to 12 weeks who participated in 444563/022 (Rota-022), 444563/033 (Rota-033), 103477 (Rota-039) and 104480 (Rota-048)
114450 Completed A randomized, double-blind, placebo-controlled first time into human study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of intranasal dosing with GSK2245035, a TLR7 agonist, in healthy volunteers and allergic rhinitics Study Listed on
114451 Completed Immunogenicity and Safety Study of GSK Biologicals' Seasonal (2010-2011) Influenza Vaccine Fluarix™ in Children Previously Vaccinated With GSK Biologicals' H1N1 Vaccine Pandemrix™ Study Listed on
114452 Completed Immunogenicity and Safety Study of GSK Biologicals' Seasonal (2010-2011) Influenza Vaccine FluarixTM in Adolescents Previously Vaccinated With GSK Biologicals' H1N1 Vaccine PandemrixTM Study Listed on
114453 Completed Effect of Metformin on gut peptides , bile acids and lipid profiles in Type 2 Diabetics
114454 Terminated Immunogenicity and safety of Fluarix™/ Influsplit SSW® 2010/2011 or Pandemrix™ Study Listed on
114458 Completed A phase 2a study to evaluate the effect of rilapladib (SB-659032) on biomarkers related to the pathogenesis and progression of Alzheimer’s disease Study Listed on
114460 Completed Safety, immunogenicity and efficacy against malaria in the sporozoite challenge model of one dose of Ad35.CS.01 malaria vaccine followed by two doses of malaria 257049 vaccine in healthy malaria-naïve adults Study Listed on
114461 Completed Evaluating the impact of early versus delayed 5 alpha reductase inhibitor treatment on the risk of emergent surgery in men with benign prostatic hyperplasia
114462 Completed Evaluating the treatment patterns in men with benign prostatic hypertrophy (Marketscan database study)
114463 Completed An Open Label Extension Study with REQUIP PR for subjects from study ROP111528
114464 Completed Safety and immunogenicity of monovalent H5N1 vaccine GSK1557484A in children 6 months to < 18 years of age Study Listed on
114467 Completed A Randomized, Double-Blind Study of the Safety and Efficacy of GSK1349572 Plus Abacavir/Lamivudine Fixed-Dose Combination Therapy Administered Once Daily Compared to Atripla over 96 Weeks in HIV-1 Infected Antiretroviral Therapy Naive Adult Subjects
114469 Completed Safety of GlaxoSmithKline (GSK) Biologicals’ 10-valent pneumococcal-protein D-diphtheria toxoid-tetanus toxoid conjugate (10PN-PD-DiT) vaccine, Synflorix when administered according to the approved Prescribing Information in Korea
114470 Completed A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects
114471 Completed PGx320 Tykerb TEACH EGF105485 liver safety pharmacogenetics
114472 Completed A Placebo-Controlled, Four-Period Crossover, Single Ascending Oral Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of the CCR9 Receptor Antagonist GSK1605786 in Japanese Healthy Male Subject
114479 Completed A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase II Study to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Once-Daily Dosing of the Oral Motilin Receptor Agonist GSK962040, in Type I and II Diabetic Male and Female Subjects with Gastroparesis
114482 Completed Demonstrating the clinical and economic benefit of 5 Alpha Reductase Inhibitor adherence in Benign Prostatic Hyperplasia
114490 Completed Phase I study of colistin methanesulfonate sodium (CMS-Na) -A randomized, double blind, placebo controlled, single and repeat dose study to investigate the safety, tolerability, and pharmacokinetics of CMS-Na in healthy Japanese male subjects -
114495 Completed An observer-blind safety and immunogenicity study of GSK Biologicals’ A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340272A in children 3 to less than 10 years old Study Listed on
114496 Completed A randomised, double-blind, multi-centre study to evaluate the efficacy and safety of inhaled fluticasone furoate in the treatment of persistent asthma in adults and adolescents currently receiving mid to high strength inhaled corticosteroids. Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.